Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Opinion leadership Stories

2013-12-13 20:21:00

CHAPEL HILL, N.C., Dec. 13, 2013 /PRNewswire/ -- In today's pharmaceutical marketplace, an organization's success is closely linked to their ability to build, maintain, and manage relationships with Key Opinion Leaders (KOLs). KOLs play a critical role in educating the medical and scientific communities and in building awareness about the latest medical therapies and novel mechanisms of action. As KOL relationship management continues to change, leaders must learn how to maximize their KOL...

2012-11-19 12:25:45

CHAPEL HILL, N.C., Nov. 19, 2012 /PRNewswire/ -- The advocacy of Key Opinion Leaders (KOLs) has proven to be among of the most effective and critical means of building product awareness in the medical and scientific communities. However, according to "Optimizing Key Opinion Leader Relationships: Best Practices in KOL Management," the latest 2012 update to an ever-growing portfolio of thought leader research, some companies are still struggling to gain traction in this critical...

2012-06-01 10:21:41

CHAPEL HILL, N.C., June 1, 2012 /PRNewswire/ -- Medical Science Liaisons build relationships between the pharmaceutical industry and key stakeholders in the marketplace. In recent years, the role of Medical Science Liaisons (MSLs) has expanded across a diverse set of customers that now include regional thought leaders, important clinical investigators, local opinion leaders, payers and government thought leaders. In the face of these growing responsibilities, many...

2012-03-28 23:00:12

In a 2012 study by Health Connexions, a healthcare consulting company, we looked at an expanded set of criteria for physician Key Opinion Leaders. The research highlighted a number of things to consider when trying to decipher who influences medical practice in a particular area. Toronto, ON (PRWEB) March 28, 2012 In a 2012 study by Health Connexions, a healthcare consulting company, we looked at an expanded set of criteria for physician Key Opinion Leaders, which included the following:...

2012-03-16 23:01:22

New research study “Meeting KOL Needs: What Pharma Needs to Know” drawn up by FirstWord has been recently published by Market Publishers Ltd. The study reveals that with the implementation this year of the PPSA, the role of the key opinion leader (KOL) is about to come under scrutiny. London, UK (PRWEB) March 15, 2012 With the implementation this year of the Physician Payment Sunshine Act (PPSA), that role of the key opinion leader (KOL) is about to come under scrutiny once...

2012-02-03 14:37:00

CHAPEL HILL, N.C., Feb. 3, 2012 /PRNewswire/ -- Medical Science Liaisons have become a key link between the pharmaceutical industry and key stakeholders such as thought leaders that drive marketplace success. And the role of MSLs will grow even more in the coming years as the pharmaceutical industry relies on them to build relationships across a diverse set of customers. A majority of 35 medical services leaders believe their MSL services will increase over the next two years,...

2011-12-09 12:59:00

CHAPEL HILL, N.C., Dec. 9, 2011 /PRNewswire/ -- Thought leaders play a critical role throughout the development cycle of new pharmaceutical products. In the pre-clinical stage, they serve as technical experts, in Phase I, II and III they are the clinical trial leaders and from pre-launch through patent expiry they are peer influencers. Clearly, success in the pharmaceutical sector is linked to an organization's ability to build, maintain and manage relationships with Key Opinion Leaders...

2011-08-22 20:05:00

CHAPEL HILL, N.C., Aug. 22, 2011 /PRNewswire/ -- With the support of Key Opinion Leaders clearly linked to success in the marketplace, competition for the time and attention of KOLs is intensifying. But the changing regulatory and access environment has altered the landscape for creating and maintaining KOL and physician relationships. To help biopharma organizations navigate this new KOL landscape, Best Practices, LLC has published an updated MSL-focused report that highlights the...

2011-03-21 17:11:00

CHAPEL HILL, N.C., March 21, 2011 /PRNewswire/ -- Although top bio-pharmaceutical companies agree that Key Opinion Leader support is critical in the successful launch of a new product, increasing competition has made it difficult to maintain high levels of KOL engagement. Consequently, the role of Medical Science Liaisons (MSLs) in forging relationships with these thought leaders has grown dramatically in recent years. In fact, today, MSL involvement in identifying and forging...

2010-11-05 16:36:00

CHAPEL HILL, N.C., Nov. 5, 2010 /PRNewswire/ -- Marketing strategies that engage the influential scientific and medical thought leaders in a particular therapeutic area are critical to launching a successful product in today's crowded Diabetes marketplace. According to a recently released report from Best Practices, LLC, "Educating the Marketplace to Support Successful Diabetes Product Launches" (click link to download a complimentary research excerpt), companies signaled Phase II as the...